戻る Agenda
Session 3B: Advancing Africa’s Clinical Trial Ecosystem: From Readiness to Global Competitiveness
Session Chair(s)
Elizabeth C. Smith
Deputy Director, Regulatory Affairs, Gates Foundation, United States
Christopher Obwanga
Sr. Director, Clinical Operations, Africa, IQVIA, Kenya
Africa presents the opportunity to move from being an underrepresented (<4% of Global trials) trial location to becoming a globally competitive clinical research partner. To increase Africa’s participation, a coordinated and integrated approach across regulatory and ethics review, research infrastructure, investigator and workforce development, earl-phase clinical trial capability, community engagement genomic representation, digital systems and sustainable investment is required. The session will bring together diverse stakeholders across the clinical trial value chain to identify practical actions that can increase access and impact of clinical trials conducted across Africa.
Speaker(s)
Speaker
Ola Abd Elghany
Manager of protocol and studies follow up administration , Egyptian Drug Authority, Egypt
Speaker
Wilfred Gurupira
Global Health & Clinical Research Executive, Africa Clinical Research Network (ACRN), Zimbabwe
Speaker
Kwasi Nyarko, MD
Technical Officer, Implementation Research Portfolio Coordinator,AVAREF Secret, WHO-AFRO, Congo, Democratic Republic of the